Exciting new technology is created every year in the life science research industry. This includes new software tools, content databases, and laboratory technologies that could vastly improve the scientific community’s ability to develop and administer new medical treatments.
Sadly, many if not most of these technologies never reach their full commercial potential simply because they are not well understood by the research scientists and/or medical professionals that might benefit from them.
SciLexis, Inc. was founded in 2019 by Scott Hutton to help life science technology businesses reach their financial potential by improving communication of the value their inventions can provide to well defined customers.
Scott’s 30+ years of experience in the pharmaceutical research industry has focused on the development and commercialization of informatics tools, databases and laboratory services that improve the drug discovery and development process.
Learn more about Scott Hutton on LinkedIn